Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

160 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves.
Bezzio C, Vernero M, Costa S, Armuzzi A, Fiorino G, Ardizzone S, Roselli J, Carparelli S, Orlando A, Caprioli FA, Castiglione F, Viganò C, Ribaldone DG, Zingone F, Monterubbianesi R, Imperatore N, Festa S, Daperno M, Scucchi L, Ferronato A, Pastorelli L, Alimenti E, Balestrieri P, Ricci C, Cappello M, Felice C, Coppini F, Alvisi P, Di Luna I, Gerardi V, Variola A, Mazzuoli S, Lenti MV, Saibeni S; Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD)’s COVID-19 Study Group. Bezzio C, et al. Among authors: caprioli fa. BMC Gastroenterol. 2023 Jul 5;23(1):230. doi: 10.1186/s12876-023-02841-0. BMC Gastroenterol. 2023. PMID: 37407913 Free PMC article.
Reduction of CD68+ macrophages and decreased IL-17 expression in intestinal mucosa of patients with inflammatory bowel disease strongly correlate with endoscopic response and mucosal healing following infliximab therapy.
Caprioli F, Bosè F, Rossi RL, Petti L, Viganò C, Ciafardini C, Raeli L, Basilisco G, Ferrero S, Pagani M, Conte D, Altomare G, Monteleone G, Abrignani S, Reali E. Caprioli F, et al. Inflamm Bowel Dis. 2013 Mar-Apr;19(4):729-39. doi: 10.1097/MIB.0b013e318280292b. Inflamm Bowel Dis. 2013. PMID: 23448791
Mongersen, an oral SMAD7 antisense oligonucleotide, and Crohn's disease.
Monteleone G, Neurath MF, Ardizzone S, Di Sabatino A, Fantini MC, Castiglione F, Scribano ML, Armuzzi A, Caprioli F, Sturniolo GC, Rogai F, Vecchi M, Atreya R, Bossa F, Onali S, Fichera M, Corazza GR, Biancone L, Savarino V, Pica R, Orlando A, Pallone F. Monteleone G, et al. N Engl J Med. 2015 Mar 19;372(12):1104-13. doi: 10.1056/NEJMoa1407250. N Engl J Med. 2015. PMID: 25785968 Free article. Clinical Trial.
PNPLA3 148M Carriers with Inflammatory Bowel Diseases Have Higher Susceptibility to Hepatic Steatosis and Higher Liver Enzymes.
Mancina RM, Spagnuolo R, Milano M, Brogneri S, Morrone A, Cosco C, Lazzaro V, Russo C, Ferro Y, Pingitore P, Pujia A, Montalcini T, Doldo P, Garieri P, Piodi L, Caprioli F, Valenti L, Romeo S. Mancina RM, et al. Inflamm Bowel Dis. 2016 Jan;22(1):134-40. doi: 10.1097/MIB.0000000000000569. Inflamm Bowel Dis. 2016. PMID: 26355465 Free PMC article.
A Health Technology-Related Cost Description Concerning Italian Ibd Centres Dealing With Crohn's Disease Results From Sole Study.
Lazzaro C, Cappello M, Cortelezzi C, Costantino G, Fiorino G, Mastronardi M, Giannotta M, Galletti B, Cicala M, Vadalà di Prampero S, Gualberti G, Caprioli F, Gasbarrini A, Fattore G. Lazzaro C, et al. Value Health. 2014 Nov;17(7):A370. doi: 10.1016/j.jval.2014.08.841. Epub 2014 Oct 26. Value Health. 2014. PMID: 27200785 Free article. No abstract available.
160 results